Newly discovered protein blocks sleeping sickness 

Newly discovered protein blocks sleeping sickness 

New research by the lab of Prof. Jo Van Ginderachter (VIB Center for Inflammation Research and VUB), in collaboration with Prof. Carl De Trez (VUB) and others, identifies a protein that could pave the way toward drugs against sleeping sickness.

February 28, 2024
Erosion blockade breakthrough: clinical trial signals hope for hand osteoarthritis

Erosion blockade breakthrough: clinical trial signals hope for hand osteoarthritis

Researchers at the Ghent University Hospital, Ghent University, and VIB-UGent Center for Inflammation Research, show that antibody therapy can be effective against erosive hand osteoarthritis. Using the antibody denosumab leads to bone remodeling and the prevention of erosive joint damage. This is the first evidence that erosive progression can be halted in this disease. The results appear in Nature Medicine.

February 15, 2024

Use it or lose it: How seagrasses conquered the sea

Use it or lose it: How seagrasses conquered the sea

Gene analyses revealing the capacity of marine flowering plants to exist under changing environmental conditions provide clues for the conservation and sustainable use of important ecosystems

January 30, 2024

Researchers map cell composition of metastatic melanoma and identify cause of immunotherapy resistance

Researchers map cell composition of metastatic melanoma and identify cause of immunotherapy resistance

Targeting mesenchymal-like melanoma cells could instigate immunotherapy response

January 9, 2024

From goblet cells to gut health: the role of AGR2 and mucus

From goblet cells to gut health: the role of AGR2 and mucus

The AGR2 protein plays a pivotal role in regulating intestinal mucus production through its interaction with IRE1β, revealing a crucial mechanism for maintaining a healthy gut environment

January 8, 2024

Belgian researchers find a crack in the wall of WHO’s top priority pathogens

Belgian researchers find a crack in the wall of WHO’s top priority pathogens

SlyB protein acts as a lifebuoy and protects bacteria from dying

December 14, 2023

Contact us

Joran Lauwers .jpg

Joran Lauwers

Science & Business Communications Expert, VIB

About VIB

VIB’s core mission is to generate disruptive insights in the molecular underpinning of life and to translate these actively into impactful innovations for patients and society. VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research. As such, they are pushing the boundaries of what we know about molecular mechanisms and how they rule living organisms such as human beings, animals, plants, and microorganisms. Based on a close partnership with five Flemish universities – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University – and supported by a solid funding program, VIB unites the expertise of all its collaborators and research groups in a single institute. VIB’s technology transfer activities translate research results into concrete benefits for society such as new diagnostics and therapies and agricultural innovations. These applications are often developed by young start-ups from VIB or through collaborations with other companies. This also leads to additional employment and bridges the gap between scientific research and entrepreneurship. VIB also engages actively in the public debate on biotechnology by developing and disseminating a wide range of science-based information. 

More info can be found on www.vib.be.

Contact